Skip to main content
OpenTrials

Clinical trial condition

Bone Marrow Diseases

Explore clinical trials studying Bone Marrow Diseases. Study availability and eligibility vary by location and protocol.

3,005 public trials 529 recruiting studies
Refine in advanced search Browse all conditions

Bone Marrow Diseases trial results

Recruiting

Testing the Anti-cancer Drug, Cirtuvivint, and Its Combination With ASTX727 to Improve Outcomes in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndromes

NCT06484062

Conditions
Acute Myeloid Leukemia, Bone Marrow Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +18 more
Locations
  • Yale University New Haven, Connecticut, United States
  • Emory University Hospital/Winship Cancer Institute Atlanta, Georgia, United States
  • University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States
  • UC Comprehensive Cancer Center at Silver Cross New Lenox, Illinois, United States
View all 22 locations
View Trial Details
Recruiting

Haplo-Cord HSCT for AML/MDS

NCT07588360

Conditions
AML (Acute Myeloid Leukemia), Anemia, Anemia, Refractory, +11 more
Locations
  • Fujian Medical University Union Hospital Fuzhou, Fujian, China
  • Guangdong Provincial People's Hospital Guangzhou, Guangdong, China
  • Sichuan Provincial People's Hospital Chengdu, Sichuan, China
  • Chinese PLA General Hospital Beijing, China
View Trial Details
Recruiting

Faecal Microbiota Transplantation After Allogeneic Stem Cell Transplantation

NCT04935684

Conditions
Acute Leukemia in Remission, Bone Marrow Diseases, Chronic Disease, +27 more
Locations
  • Service d'Hématologie Clinique et Thérapie Cellulaire CHU Amiens Picardie - Site Sud Amiens, France
  • Service Maladies du sang CHU Angers Angers, France
  • Hématologie clinique CHU Besançon Besançon, France
  • Plateforme d'Investigation Clinique / Centre d'Investigation Clinique - Inserm 1405, CHU Gabriel Montpied Clermont-Ferrand Clermont-Ferrand, France
View all 20 locations
View Trial Details
Recruiting

A Study of Mavorixafor in Participants With Congenital and Acquired Primary Autoimmune and Idiopathic Chronic Neutropenic Disorders Who Are Experiencing Recurrent and/or Serious Infections

NCT06056297

Conditions
Abnormalities, Multiple, Agranulocytosis, Autoimmune Diseases, +31 more
Locations
  • Phoenix Children's Hospital Phoenix, Arizona, United States
  • UC Irvine Irvine, California, United States
  • Orso Health La Jolla, California, United States
  • University of California, Los Angeles-UCLA Los Angeles, California, United States
View all 114 locations
View Trial Details

Related conditions